台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效

中裕

(4147)
可現股當沖
  • 股價
    53.7
  • 漲跌
    ▲0.5
  • 漲幅
    +0.94%
  • 成交量
    813
  • 產業
    上櫃 生技醫療類股
  • 319人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
中裕 (4147)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2026/02/11     後一日»

券商獲利排行 - 2026/02/11

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  0.65%74.8-8.983.71862173153.253.35353.7
  1.11%44.17.13763751253.253.153.753.7
  0.62%17.63.514.131532253.353.253.453.7
  1.02%10.8010.82020053.253.2053.7
  0.72%8.108.12121053.353.3053.7
  1.36%7.207.2101005353053.7
  1.32%7079100535352.853.7
  1.24%6.606.6101005353053.7
  0.57%6.43.72.75211653.353.253.453.7
  0.51%6.36.6-0.30222353.253.153.453.7
  0.41%6.106.12828053.553.5053.7
  0.94%6061212053.253.2053.7
  1.13%6061010053.153.1053.7
  1.09%5.805.81010053.153.1053.7
  1.70%4.504.555052.852.8053.7
  1.38%4.404.46605353053.7
  0.89%3.303.377053.253.2053.7
  1.53%3.20.42.934152.852.753.153.7
  0.73%3.14-0.9-35853.152.653.453.7
  1.13%30355053.153.1053.7
  0.66%2.82.800885352.953.253.7
  1.70%2.702.733052.852.8053.7
  1.70%2.702.733052.852.8053.7
  0.94%2.502.555053.253.2053.7
  1.44%2.302.333052.952.9053.7
  2.09%2.202.222052.652.6053.7
  1.80%1.901.922052.852.853.253.7
  1.77%1.90.81.102152.952.653.453.7
  1.13%1.801.833053.153.1053.7
  1.06%1.7-0.11.823152.852.852.753.7
  1.50%1.60.80.812153.252.953.753.7
  0.44%1.40.50.926453.353.253.453.7
  1.13%1.201.222053.153.1053.7
  0.75%1.21.2003353.152.953.353.7
  2.09%1.101.111052.652.6053.7
  0.94%10122053.253.2053.7
  0.94%10122053.253.2053.7
  0.94%10122053.253.2053.7
  1.90%10111052.752.7053.7
  1.90%10111052.752.7053.7
  1.90%10111052.752.7053.7
  1.90%10111052.752.7053.7
  1.90%10111052.752.7053.7
  1.90%10111052.752.7053.7
  1.90%10111052.752.7053.7
  1.90%10111052.752.7053.7
  0.31%11006653.353.253.353.7
  0.62%110-21353.552.753.753.7
  1.88%11001153.152.653.653.7
  0.07%0.900.92323053.753.7053.7

券商虧損排行 - 2026/02/11

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -0.75%-84.19.1-93.2-1625021253.152.953.153.7
  -1.45%-37.6-0.4-37.2-4814952.953.352.953.7
  -0.75%-21.5-2.2-19.3-41135453.353.453.253.7
  -0.65%-20.5-0.2-20.3-33255953.153.153.153.7
  -1.76%-13.90-13.9-1501552.8052.853.7
  -0.86%-11.40-11.4-2502553.2053.253.7
  -0.75%-9.91.7-11.6-186255352.853.153.7
  -0.85%-6.80.2-7-1411553.25353.253.7
  -0.85%-6.30-6.3-1401453.3053.353.7
  -1.57%-5.80-5.8-70752.9052.953.7
  -1.17%-4.3-0.8-3.5-52753.153.45353.7
  -1.16%-4.30-4.3-51753535353.7
  -0.75%-40-4-1001053.3053.353.7
  -0.94%-40-4-80853.2053.253.7
  -1.16%-3.7-1.4-2.3-33653.153.452.953.7
  -1.56%-3.30-3.3-40452.9052.953.7
  -1.90%-30-3-30352.7052.753.7
  -1.70%-2.70-2.7-30352.8052.853.7
  -1.64%-2.60-2.6-30352.8052.853.7
  -0.94%-2.50-2.5-50553.2053.253.7
  -0.56%-2.40-2.4-80853.4053.453.7
  -1.03%-2.20-2.2-40453.2053.253.7
  -0.75%-20-2-50553.3053.353.7
  -0.94%-20-2-40453.2053.253.7
  -1.90%-20-2-20252.7052.753.7
  -1.90%-20-2-20252.7052.753.7
  -1.69%-1.8-0.9-0.9-11253.153.752.853.7
  -0.54%-1.70.6-2.4-3265352.853.153.7
  -1.51%-1.60-1.6-20252.9052.953.7
  -1.51%-1.60-1.6-20252.9052.953.7
  -0.40%-1.50-1.5-70753.5053.553.7
  -0.94%-1.50-1.5-30353.2053.253.7
  -0.55%-1.50.1-1.6-41553.353.253.353.7
  -1.32%-1.40-1.4-2025305353.7
  -1.32%-1.40-1.4-2025305353.7
  -1.23%-1.30-1.3-20253.1053.153.7
  -1.13%-1.20-1.2-20253.1053.153.7
  -1.13%-1.20-1.2-20253.1053.153.7
  -1.13%-1.20-1.2-20253.1053.153.7
  -1.03%-1.1-0.5-0.6-11253.353.653.153.7
  -2.09%-1.10-1.1-10152.6052.653.7
  -0.94%-10-1-20253.2053.253.7
  -1.76%-0.90-0.9-10152.853.452.853.7
  -1.70%-0.90-0.9-10152.8052.853.7
  -1.70%-0.90-0.9-10152.8052.853.7
  -0.66%-0.70-0.7-20253.4053.453.7
  -0.66%-0.70-0.7-10253.352.953.453.7
  -1.32%-0.70-0.7-1015305353.7
  -1.32%-0.70-0.7-1015305353.7
  -1.32%-0.70-0.7-1015305353.7
中裕持續拓展海外 與俄羅斯R-Pharm簽署指定患者藥物使用計劃供應協議Anue鉅亨-2025/12/01
中裕愛滋新藥與CDMO雙箭齊發 明年營收有望優於今年Anue鉅亨-2025/08/22
中裕 相關文章